- FoI Number
- 2022-712
- Subject
- Biologic Medicine
- Date Received
- 06/02/2023
- Request and Response
-
1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs?
- Adalimumab – Humira 2
- Adalimumab Biosimilar 12
- Filgotinib 1
- Golimumab 0
- Infliximab – Remicade 0
- Infliximab Biosimilar 2
- Ozanimod 0
- Tofacitinib 0
- Upadacitinib 0
- Ustekinumab 2
- Vedolizumab 2
2. If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Crohn's Disease ONLY with the following biologic drugs?
- Adalimumab - Humira
- Adalimumab Biosimilar
- Golimumab
- Infliximab - Remicade
- Infliximab Biosimilar
- Upadacitinib
- Ustekinumab
- Vedolizumab
In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland do not collect this data.
